Non-invasive Prediction of Molecular and Histopathological Subtypes in Murine and Human Pancreatic Ductal Adenocarcinoma Using [18F]FDG PET
Year: 2026
Type: preprint
Abstract: Purpose This study evaluates the utility of [ 18 F]fluorodeoxyglucose positron emission tomography ([ 18 F]FDG PET) for Pancreatic ductal adenocarcinoma (PDAC) subtype differentiation across preclinical and clinical settings, and assesses the impact of tracer uptake timing on subtype discrimination. Methods [ 18 F]FDG uptake was investigated in classical (C)-HPAC and quasi-mesenchymal (QM)-PSN1 cells, heterotopic rat (n = 11), orthotopic mouse xenografts (n = 8), and gland-forming (GF)/non-GF tumors from seven genetically engineered mouse models (GEMMs). Retrospective [ 18 F]FDG PET data from 16 PDAC patients were analyzed using subtype classification based on keratin-81 (KRT81+(QM)/KRT81-(non-QM)). Dynamic and static [ 18 F]FDG PET parameters, including standard uptake value (SUV) mean , SUV max , and mean tumor-to-muscle ratio (T/M mean ), were evaluated for subtype discrimination. Results QM tumors showed significantly higher [ 18 F]FDG uptake than C tumors in vitro (50.7 ± 1.03% vs. 19.4 ± 2.37%), in heterotopic (SUV max 6.91 ± 1.14 vs. 2.66 ± 0.28), and orthotopic (SUV max 2.85 ± 0.70 vs. 1.45 ± 0.50) xenografts. Non-GF tumors also showed significantly higher uptake than GF (SUV max 3.94 ± 0.70 vs. 2.53 ± 0.97). Patients showed a similar trend (SUV max 6.33 ± 1.74 vs. 4.95 ± 1.46), with shorter overall survival in QM tumors. Dynamic PET revealed continued tracer accumulation in QM/non-GF tumors throughout the 90-minute acquisition period, whereas C/GF tumors approached a plateau by approximately 60 minutes. T/M mean showed the best classification performance across all models. Conclusion [ 18 F]FDG PET differentiated PDAC subtypes across all preclinical models with a similar but less pronounced trend in patients. Later imaging time points showed enhanced metabolic separation, suggesting potential benefits for improving non-invasive subtype discrimination. Clinical Trial Registration N/A
Source: Research Square
Authors: Romina Karampour, Irina Heid
Institutions: TUM Klinikum, Technical University of Munich
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236588809
